BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 12545173)

  • 1. Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation.
    Latour S; Roncagalli R; Chen R; Bakinowski M; Shi X; Schwartzberg PL; Davidson D; Veillette A
    Nat Cell Biol; 2003 Feb; 5(2):149-54. PubMed ID: 12545173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAP couples Fyn to SLAM immune receptors.
    Chan B; Lanyi A; Song HK; Griesbach J; Simarro-Grande M; Poy F; Howie D; Sumegi J; Terhorst C; Eck MJ
    Nat Cell Biol; 2003 Feb; 5(2):155-60. PubMed ID: 12545174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between SAP and FynT: Inducible SH3 domain-mediated interaction controlled by engagement of the SLAM receptor.
    Chen R; Latour S; Shi X; Veillette A
    Mol Cell Biol; 2006 Aug; 26(15):5559-68. PubMed ID: 16847311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SAP increases FynT kinase activity and is required for phosphorylation of SLAM and Ly9.
    Simarro M; Lanyi A; Howie D; Poy F; Bruggeman J; Choi M; Sumegi J; Eck MJ; Terhorst C
    Int Immunol; 2004 May; 16(5):727-36. PubMed ID: 15096483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-causing SAP mutants are defective in ligand binding and protein folding.
    Li C; Iosef C; Jia CY; Gkourasas T; Han VK; Shun-Cheng Li S
    Biochemistry; 2003 Dec; 42(50):14885-92. PubMed ID: 14674764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
    Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
    Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family.
    Lewis J; Eiben LJ; Nelson DL; Cohen JI; Nichols KE; Ochs HD; Notarangelo LD; Duckett CS
    Clin Immunol; 2001 Jul; 100(1):15-23. PubMed ID: 11414741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual functional roles for the X-linked lymphoproliferative syndrome gene product SAP/SH2D1A in signaling through the signaling lymphocyte activation molecule (SLAM) family of immune receptors.
    Li C; Iosef C; Jia CY; Han VK; Li SS
    J Biol Chem; 2003 Feb; 278(6):3852-9. PubMed ID: 12458214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The XLP syndrome protein SAP interacts with SH3 proteins to regulate T cell signaling and proliferation.
    Li C; Schibli D; Li SS
    Cell Signal; 2009 Jan; 21(1):111-9. PubMed ID: 18951976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A.
    Li SC; Gish G; Yang D; Coffey AJ; Forman-Kay JD; Ernberg I; Kay LE; Pawson T
    Curr Biol; 1999 Dec; 9(23):1355-62. PubMed ID: 10607564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells.
    Morra M; Lu J; Poy F; Martin M; Sayos J; Calpe S; Gullo C; Howie D; Rietdijk S; Thompson A; Coyle AJ; Denny C; Yaffe MB; Engel P; Eck MJ; Terhorst C
    EMBO J; 2001 Nov; 20(21):5840-52. PubMed ID: 11689425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product.
    Latour S; Gish G; Helgason CD; Humphries RK; Pawson T; Veillette A
    Nat Immunol; 2001 Aug; 2(8):681-90. PubMed ID: 11477403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A.
    Shlapatska LM; Mikhalap SV; Berdova AG; Zelensky OM; Yun TJ; Nichols KE; Clark EA; Sidorenko SP
    J Immunol; 2001 May; 166(9):5480-7. PubMed ID: 11313386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The X-linked lymphoproliferative disease gene product SAP associates with PAK-interacting exchange factor and participates in T cell activation.
    Gu C; Tangye SG; Sun X; Luo Y; Lin Z; Wu J
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14447-52. PubMed ID: 16983070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional requirements for interactions between CD84 and Src homology 2 domain-containing proteins and their contribution to human T cell activation.
    Tangye SG; Nichols KE; Hare NJ; van de Weerdt BC
    J Immunol; 2003 Sep; 171(5):2485-95. PubMed ID: 12928397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A "three-pronged" binding mechanism for the SAP/SH2D1A SH2 domain: structural basis and relevance to the XLP syndrome.
    Hwang PM; Li C; Morra M; Lillywhite J; Muhandiram DR; Gertler F; Terhorst C; Kay LE; Pawson T; Forman-Kay JD; Li SC
    EMBO J; 2002 Feb; 21(3):314-23. PubMed ID: 11823424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM.
    Sayos J; Wu C; Morra M; Wang N; Zhang X; Allen D; van Schaik S; Notarangelo L; Geha R; Roncarolo MG; Oettgen H; De Vries JE; Aversa G; Terhorst C
    Nature; 1998 Oct; 395(6701):462-9. PubMed ID: 9774102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic evidence linking SAP, the X-linked lymphoproliferative gene product, to Src-related kinase FynT in T(H)2 cytokine regulation.
    Davidson D; Shi X; Zhang S; Wang H; Nemer M; Ono N; Ohno S; Yanagi Y; Veillette A
    Immunity; 2004 Nov; 21(5):707-17. PubMed ID: 15539156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and immunological basis of X-linked lymphoproliferative disease.
    Latour S; Veillette A
    Immunol Rev; 2003 Apr; 192():212-24. PubMed ID: 12670406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-linked lymphoproliferative disease: a progressive immunodeficiency.
    Morra M; Howie D; Grande MS; Sayos J; Wang N; Wu C; Engel P; Terhorst C
    Annu Rev Immunol; 2001; 19():657-82. PubMed ID: 11244050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.